Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWHomocarnosine is a dipeptide composed of GABA and L-histidine that has been found in cerebrospinal fluid and the brain.1 It inhibits lipid peroxidation induced by AAPH (Item No. 82235) when used at a concentration of 10 mM.2 Homocarnosine (1 mM) decreases lactate dehydrogenase (LDH) and prostaglandin E2 (PGE2; Item No. 14010) release from PC12 cells in an in vitro model of ischemia induced by oxygen-glucose deprivation.3 It reduces infarct area and neurological deficit scores in a rat model of cerebral ischemia-reperfusion injury induced by middle cerebral artery occlusion (MCAO).4 Homocarnosine (5 mg/animal) reduces mortality in a mouse model of subcutaneous S. aureus infection.5
WARNING This product is not for human or veterinary use.
1. Carnosine and related substances in animal tissues. Comp. Biochem. Physiol. 34(1), 3-30 (1970).
2. Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc. Natl. Acad. Sci. USA 85(9), 3175-3179 (1988).
3. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J. Neurosci. Res. 68(4), 463-469 (2002).
4. L-
5. Prophylactic effects of γ-